Manhattan Scientifics Inc. (MHTX) Financials Nov 1
Post# of 250675
Posted On: 11/17/2014 3:06:06 AM
Manhattan Scientifics Inc. (MHTX) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Manhattan Scientifics Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 633,000 1.69M 687,000 693,000 652,000
Cost of Goods Sold (COGS) incl. D&A 35,000 131,000 233,000 182,000 227,000
COGS excluding D&A 0 98,000 112,000 0 0
Depreciation & Amortization Expense 35,000 33,000 121,000 182,000 227,000
Depreciation 0 0 12,000 - -
Amortization of Intangibles 35,000 33,000 109,000 182,000 -
Gross Income 598,000 1.56M 454,000 511,000 425,000
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 995,000 1.55M 2.62M 2.16M 2.23M
Research & Development 25,000 28,000 204,000 274,000 960,000
Other SG&A 970,000 1.52M 2.42M 1.89M 1.27M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 (33,000) 0
EBIT after Unusual Expense 0 0 0 33,000 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 1,000 0 0 0 0
Equity in Affiliates (Pretax) 0 - - - 0
Interest Expense 50,000 50,000 117,000 473,000 120,000
Gross Interest Expense 50,000 50,000 117,000 473,000 120,000
Interest Capitalized 0 0 0 0 0
Pretax Income (446,000) (43,000) (2.29M) (2.09M) (1.93M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (446,000) (43,000) (2.29M) (2.09M) (1.93M)
Minority Interest Expense 0 0 0 0 0
Net Income (446,000) (43,000) (2.29M) (2.09M) (1.93M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (446,000) (43,000) (2.29M) (2.09M) (1.93M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (446,000) (43,000) (2.29M) (2.09M) (1.93M)
EPS (Basic) 0.00 0.00 0.00 () ()
Basic Shares Outstanding 393.16M 401.92M 425.58M 449.7M 461.11M
EPS (Diluted) 0.00 0.00 0.00 () ()
Diluted Shares Outstanding 393.16M 401.92M 425.58M 449.7M 461.11M
EBITDA (362,000) 40,000 (2.05M) (1.47M) (1.58M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Manhattan Scientifics Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 633,000 1.69M 687,000 693,000 652,000
Cost of Goods Sold (COGS) incl. D&A 35,000 131,000 233,000 182,000 227,000
COGS excluding D&A 0 98,000 112,000 0 0
Depreciation & Amortization Expense 35,000 33,000 121,000 182,000 227,000
Depreciation 0 0 12,000 - -
Amortization of Intangibles 35,000 33,000 109,000 182,000 -
Gross Income 598,000 1.56M 454,000 511,000 425,000
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 995,000 1.55M 2.62M 2.16M 2.23M
Research & Development 25,000 28,000 204,000 274,000 960,000
Other SG&A 970,000 1.52M 2.42M 1.89M 1.27M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 (33,000) 0
EBIT after Unusual Expense 0 0 0 33,000 0
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 1,000 0 0 0 0
Equity in Affiliates (Pretax) 0 - - - 0
Interest Expense 50,000 50,000 117,000 473,000 120,000
Gross Interest Expense 50,000 50,000 117,000 473,000 120,000
Interest Capitalized 0 0 0 0 0
Pretax Income (446,000) (43,000) (2.29M) (2.09M) (1.93M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (446,000) (43,000) (2.29M) (2.09M) (1.93M)
Minority Interest Expense 0 0 0 0 0
Net Income (446,000) (43,000) (2.29M) (2.09M) (1.93M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (446,000) (43,000) (2.29M) (2.09M) (1.93M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (446,000) (43,000) (2.29M) (2.09M) (1.93M)
EPS (Basic) 0.00 0.00 0.00 () ()
Basic Shares Outstanding 393.16M 401.92M 425.58M 449.7M 461.11M
EPS (Diluted) 0.00 0.00 0.00 () ()
Diluted Shares Outstanding 393.16M 401.92M 425.58M 449.7M 461.11M
EBITDA (362,000) 40,000 (2.05M) (1.47M) (1.58M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)